1209458-91-2 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 5-bromo-1,3-thiazole-2-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structural features and reactivity make it an essential component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 5-bromo-1,3-thiazole-2-carboxylate serves as a vital intermediate for the production of agrochemicals. Its properties and reactivity are harnessed to create novel compounds that can be used in the development of pesticides, herbicides, and other agricultural chemicals, thereby enhancing crop protection and yield.
Used in Organic Synthesis:
Methyl 5-bromo-1,3-thiazole-2-carboxylate is employed as a versatile building block in organic synthesis. Its structural attributes and the presence of the bromine atom make it suitable for a variety of cross-coupling and halogenation reactions, allowing for the creation of complex molecular structures with diverse applications in chemistry and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1209458-91-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,9,4,5 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1209458-91:
(9*1)+(8*2)+(7*0)+(6*9)+(5*4)+(4*5)+(3*8)+(2*9)+(1*1)=162
162 % 10 = 2
So 1209458-91-2 is a valid CAS Registry Number.
1209458-91-2Relevant academic research and scientific papers
INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
-
Page/Page column 171; 172, (2021/01/29)
The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
SELECTIVE HDAC1,2 INHIBITORS
-
Paragraph 0463; 0464; 0465, (2018/06/04)
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I
-
Page/Page column 36; 54, (2015/11/16)
The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II
-
Page/Page column 30, (2015/12/11)
The invention relates to amidic oxotetrahydro-2H-furo[3.2-b]pyrrol-4(5H)-yl) derivatives as dual CatS/K inhibitors exhibiting a pronounced CatK-inhibition, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
